Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
behavioural outcomes to in vivo PET imaging and molecular measures, the project aims to clarify the role of GPR6 in dopamine-related brain function and its potential as a therapeutic target for depression
-
take approaches combining mouse developmental genetics, cell-type-specific viral tracing, ex vivo electrophysiology, opto/chemogenetics, in vivo imaging, single-nucleus RNA sequencing (snRNA-seq), and
-
-resolution microscopy Genome editing (e.g., CRISPR-based approaches) Quantitative and live-cell imaging Functional genomics The project is embedded in an interdisciplinary research environment combining
-
on an annual basis. How to apply Submit a complete application at our online portal. Click on the “Apply now” icon at the bottom of the page to apply. The documents must be in Adobe PDF or Word. Your application
-
against different operation conditions. The position is a part of a research project and prototype battery modules will be produced by one of the partners. The tasks include testing of these prototype
-
modelling, or live neural imaging is desirable Experience working with neurons and knowledge in neurobiology is desirable Track record of international mobility is highly valued Publication record is
-
synchrotron or laboratory 3D diffraction imaging is considered as a significant advantage. Excellent English communication skills are also essential As a formal qualification, you must hold a PhD degree (or
-
for downstream sequencing and imaging. Performing MALDI mass spectrometry and spatial transcriptomics to characterize biological niches within mouse and human tissue samples. Performing quantitative imaging
-
significance of bioluminescence. We will also apply a range of advanced imaging techniques to visualize the light organs and their innervation. The successful applicant will be part of a highly interdisciplinary
-
of radiotherapy, including proton therapy. This project will both aim at improving delineation and dose calculation in radiotherapy while reducing imaging dose and patient burden. The project will include